Accordingly, knockdown of METTL3 protects from development of abdominal aortic aneurysm, and this therapeutic effect is inhibitable by either miR-34a silencing or SIRT1 overexpression.86 This evidence concerns the gene METTL3 and abdominal aortic aneurysm.